Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-28 · accession 0001209191-21-071561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-29 | 2021-12-28 | ARWR | Ferrari Mauro | Dir | S - Sale | $66.82 | -3,400 | 36.6K | -9% | -$227.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-28 | S | D | 3,400 | $66.82 | 36,571 | D | — | — | (F1) The sale was made to generate proceeds to cover the tax liability incident to an upcoming vesting of restricted stock units in January 2022. (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |